Master Alliance Provisions Guide (MAPGuide)

Medigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement

  • Business model | Governance

MEDIGEN – MPP AGREEMENT

12. GOVERNING LAW AND JURISDICTION

12.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of Switzerland. Parties hereby waive of any of the privileges and immunities enjoyed under national or international law.

12.2 Jurisdiction and Dispute Resolution. The Parties shall use all reasonable efforts to solve any dispute, controversy or claim that may arise under this Agreement through good faith negotiations. In the event that the Parties are unable to resolve a dispute within sixty (60) calendar days from the date such dispute is first brought to the other Party’s attention, any dispute, controversy, or claim arising out of, or in relation to, this contract, including regarding the validity, invalidity, breach, or termination thereof, shall be resolved by arbitration in accordance with the Swiss Rules of International Arbitration of the Swiss Arbitration Centre in force on the date on which the Notice of Arbitration is submitted in accordance with those Rules. The number of arbitrators shall be three. The seat of the arbitration shall be Geneva, Switzerland. The arbitral proceedings shall be conducted in English.

12.3 If there are any disputes in connection with this Agreement, including its termination under Clause 10, all rights and obligations of the Parties shall continue until such time as any dispute has been resolved in accordance with the provisions of this Clause.

FORM OF SUBLICENSE

15. GOVERNING LAW AND JURISDICTION

15.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of Switzerland. Parties hereby waive of any of the privileges and immunities enjoyed under national or international law.

15.2 Jurisdiction and Dispute Resolution. The Parties shall use all reasonable efforts to solve any dispute, controversy or claim that may arise under this Agreement through good faith negotiations. In the event that the Parties are unable to resolve a dispute within sixty (60) calendar days from the date such dispute is first brought to the other Party’s attention, any dispute, controversy, or claim arising out of, or in relation to, this contract, including regarding the validity, invalidity, breach, or termination thereof, shall be resolved by arbitration in accordance with the Swiss Rules of International Arbitration of the Swiss Arbitration Centre in force on the date on which the Notice of Arbitration is submitted in accordance with those Rules. The number of arbitrators shall be three. The seat of the arbitration shall be Geneva, Switzerland. The arbitral proceedings shall be conducted in English.

15.3 If there are any disputes in connection with this Agreement, including its termination under Clause 12, all rights and obligations of the Parties shall continue until such time as any dispute has been resolved in accordance with the provisions of this Clause.